Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Investigative Dermatology
|
June 20, 2008
B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses
Hugo Mouquet, Philippe Musette, Marie-Lyse Gougeon, et al.
Plos One
|
November 6, 2015
Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial
Yves Allenbach, Marguerite Guiguet, Aude Rigolet, et al.
Annals of Surgery
|
April 21, 2017
Autologous Myoblasts for the Treatment of Fecal Incontinence: Results of a Phase 2 Randomized Placebo-controlled Study (MIAS)
Olivier Boyer, Valérie Bridoux, Camille Giverne, et al.
Cell Transplantation
|
January 8, 2015
Chromosomal instability but lack of transformation in human myoblast preparations
Aurélie Bisson, Stéphanie Le Corre, Géraldine Joly-Helas, et al.
Hematological Oncology
|
October 7, 2025
Routine Monitoring of CAR-T-Cells Expansion and Persistence in Patients With Aggressive Large B-Cell Lymphoma by Flow Cytometry: A Single-Center Experience
Alexandra Zduniak, Jérémie Martinet, Emilie Lévêque, et al.
The New England Journal of Medicine
|
August 10, 2007
A single cycle of rituximab for the treatment of severe pemphigus
Pascal Joly, Hugo Mouquet, Jean-Claude Roujeau, et al.
Journal of Clinical Immunology
|
May 4, 2010
B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease
Gaël Mouillot, Maryvonnick Carmagnat, Laurence Gérard, et al.
Science Translational Medicine
|
March 8, 2013
Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response
Natacha Colliou, Damien Picard, Frédérique Caillot, et al.
The Journal of Experimental Medicine
|
September 21, 2016
Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations
Yi Wang, Cindy S Ma, Yun Ling, et al.
Journal of Clinical Immunology
|
August 12, 2019
A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency
Hélène Coignard-Biehler, Nizar Mahlaoui, Benoit Pilmis, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Investigative Dermatology
|
June 20, 2008
B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses
Hugo Mouquet, Philippe Musette, Marie-Lyse Gougeon, et al.
Plos One
|
November 6, 2015
Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial
Yves Allenbach, Marguerite Guiguet, Aude Rigolet, et al.
Annals of Surgery
|
April 21, 2017
Autologous Myoblasts for the Treatment of Fecal Incontinence: Results of a Phase 2 Randomized Placebo-controlled Study (MIAS)
Olivier Boyer, Valérie Bridoux, Camille Giverne, et al.
Cell Transplantation
|
January 8, 2015
Chromosomal instability but lack of transformation in human myoblast preparations
Aurélie Bisson, Stéphanie Le Corre, Géraldine Joly-Helas, et al.
Hematological Oncology
|
October 7, 2025
Routine Monitoring of CAR-T-Cells Expansion and Persistence in Patients With Aggressive Large B-Cell Lymphoma by Flow Cytometry: A Single-Center Experience
Alexandra Zduniak, Jérémie Martinet, Emilie Lévêque, et al.
The New England Journal of Medicine
|
August 10, 2007
A single cycle of rituximab for the treatment of severe pemphigus
Pascal Joly, Hugo Mouquet, Jean-Claude Roujeau, et al.
Journal of Clinical Immunology
|
May 4, 2010
B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease
Gaël Mouillot, Maryvonnick Carmagnat, Laurence Gérard, et al.
Science Translational Medicine
|
March 8, 2013
Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response
Natacha Colliou, Damien Picard, Frédérique Caillot, et al.
The Journal of Experimental Medicine
|
September 21, 2016
Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations
Yi Wang, Cindy S Ma, Yun Ling, et al.
Journal of Clinical Immunology
|
August 12, 2019
A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency
Hélène Coignard-Biehler, Nizar Mahlaoui, Benoit Pilmis, et al.
Page
of 2